Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies.
Huth, J.R., Park, C., Petros, A.M., Kunzer, A.R., Wendt, M.D., Wang, X., Lynch, C.L., Mack, J.C., Swift, K.M., Judge, R.A., Chen, J., Richardson, P.L., Jin, S., Tahir, S.K., Matayoshi, E.D., Dorwin, S.A., Ladror, U.S., Severin, J.M., Walter, K.A., Bartley, D.M., Fesik, S.W., Elmore, S.W., Hajduk, P.J.(2007) Chem Biol Drug Des 70: 1-12
- PubMed: 17630989 
- DOI: 10.1111/j.1747-0285.2007.00535.x
- Primary Citation of Related Structures:  
2QF6, 2QFO, 2QG0, 2QG2 - PubMed Abstract: 
The molecular chaperone HSP90 has been shown to facilitate cancer cell survival by stabilizing key proteins responsible for a malignant phenotype. We report here the results of parallel fragment-based drug design approaches in the design of novel HSP90 inhibitors ...